Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Jacobio Pharmaceuticals Co., Ltd.)"
Count: 15
Selected: 0
NCT IDTitle
NCT05490472JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
NCT05288205Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
NCT05276726A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
NCT05194995JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation
NCT05174585JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
NCT05009329FIH Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation in China
NCT05002270JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
NCT04721223JAB-3068 Activity in Adult Patients With Advanced Solid Tumors
NCT04720976JAB-3312 Activity in Adult Patients With Advanced Solid Tumors
NCT04686682A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
NCT04587479A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors
NCT04121286A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
NCT04045496A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
NCT03565003A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
NCT03518554A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors